regulation

Merger set to complete 14 August

Repercussions of growing short-termism

Election resulted in hung parliament

MiFID II due to be implemented in January 2018

A Q&A with BB Biotech's Head of Investment Management Daniel Koller reveals how innovation in medicine is offering investment opportunities.

Future remains 'pretty bleak'

Sector rules changed in March

Set to publish final report

Ephraim Moss and Joshua Ashman, co-founders of Expat Tax Professionals LLC, take a closer look at key areas to watch for US expats.

Despite the uncertainty on the political front and the macroeconomic unknowns, the biotech sector's fundamentals have remained solid.